Summarizes research on the use of MDMA (street named ecstasy or molly), a synthetically derived chemical used recreationally. Less than 1% of Canadian aged 15 and older reported past-year use of ecstasy and 1 in 25 youth in grades 10–12 reported…
Summarizes recommendations that emerged from a two-day meeting we hosted with national and international experts to identify a path toward implementing a standard THC unit in Canada. It also includes key actions and considerations in areas that…
Illustrates survey results of 855 respondents sharing their recovery journey, including data on common drugs used, barriers to recovery, and resources and programs that were used during recovery.
This publication has been archived on the CCSA website and was current when it was published. It is available for reference or research purposes.
This well-established biennial event is one of the leading international conferences on harmful gambling attracting delegates from New Zealand and around the world.
Summarizes experiences of equity-deserving populations accessing virtual substance use care and provides recommendations to tailor virtual services to their realities, needs and preferences.
Illustrates key context and data on policies and training related to substance use by individuals in non–safety-sensitive positions (positions that pose low or no risk to self, co-workers, the public or the environment (e.g., office staff, retail…
In September 2025, CCSA officially submitted a response to the open consultation to Health Canada’s Third Legislative Review of the Tobacco and Vaping Products Act (TVPA).
Greene, S., Ion, A., Gabel, C., Ryan, C., Blake, M., Ali, A., Kozack, T., Griffith, G., Carinal, C., Bernier, A, & Maurice, R.
The Leadership Team at CCSA is responsible for ensuring CCSA achieves its strategic goals. The team develops strategic directions that align with the mandate of the organization and its core functions.
Examines the state of Canadian substance use policies in the workplace by surveying the literature and interviewing key informants at select companies.
Highlights the single recommended indicator for enhancing and standardizing the collection of drug-impaired driving public opinion survey data across Canada.
